# IgA Nephropathy: Mechanism to Targeted Therapy

A proteinuria reduction is clinically useful but does not by itself settle long-term kidney benefit or safety. Explain the level of evidence supporting the treatment.

![Infographic: IgA Nephropathy: Mechanism to Targeted Therapy](https://urinenephrology.org/visual-reference/images/student-iga-nephropathy.png?v=20261003c)

## Map the four-hit pathway

Galactose-deficient IgA1, antibodies against it, circulating immune complexes, and mesangial deposition form the central framework. APRIL/BAFF-directed approaches address B-cell/plasma-cell signaling; complement therapies act downstream. Endothelin and RAAS-directed treatments address injury pathways without being interchangeable immune therapies.

## Recognize the phenotype

Hematuria, proteinuria, hypertension, and declining filtration vary widely. Clinical severity is not captured by the biopsy label alone.

## Integrate biopsy and trajectory

Assess pathology, persistent proteinuria, kidney function, blood pressure, and competing causes. Prognostic tools complement rather than replace judgment.

## Measure risk and response with the same method

Record proteinuria, eGFR trajectory, BP, biopsy findings, and the chosen treatment indication before changing therapy. Optimize supportive kidney protection while evaluating disease-specific options. Recheck proteinuria and kidney function consistently; a single improved urine result is weaker evidence than a sustained response.

## Compare targets carefully

APRIL, BAFF, complement, endothelin, and targeted steroid approaches intervene at different points. Confirm trial population, endpoint, approval status, and long-term evidence for each.

## Separate approval from outcome certainty

For each agent, state the approved indication, studied population, endpoint, and follow-up. Accelerated approval based on proteinuria does not automatically establish a mortality benefit. Avoid ranking APRIL, BAFF, complement, or endothelin therapies solely by cross-trial percent reductions.

## Source lessons

- [iga nephropathy student handout](https://urinenephrology.org/student-resources/glomerular/iga-nephropathy-student-handout.html)

Read alongside the full lessons; the findings and decisions shown here require the stated clinical context.